Long Xu

Title: Long Xu: Innovator in Antibody Formulations

Introduction

Long Xu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceutical formulations. With a total of five patents to his name, he has made remarkable strides in developing stable antibody formulations that address critical health challenges.

Latest Patents

One of Long Xu's latest patents is focused on a stable antibody formulation that specifically targets the Ebola Virus (EBOV). This innovative pharmaceutical formulation includes a human antibody, a buffer, an amino acid, a non-ionic surfactant, and a stabilizer. The formulation is designed to maintain a high degree of antibody stability during transport and storage, even at elevated temperatures exceeding 40° C. Another notable patent involves a method for quantitating individual antibodies from a mixture. This method utilizes hydrophobic interaction chromatography high-performance liquid chromatography (HIC-HPLC) to separate and quantify antibody molecules, ensuring accurate measurement of each component in complex mixtures.

Career Highlights

Long Xu is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has been instrumental in enhancing the stability and efficacy of antibody-based therapies.

Collaborations

Long Xu collaborates with esteemed colleagues, including Dingjiang Liu and Lin Luo, who contribute to his innovative projects and research initiatives.

Conclusion

Long Xu's contributions to the field of antibody formulations exemplify the impact of innovation in healthcare. His patents not only advance scientific knowledge but also hold the potential to improve treatment options for serious diseases.